[DOI] [PubMed] [Google Scholar] 23.Sikiric P., Rucman R., Turkovic B., Sever M., Klicek R., Radic B., Drmic D., Stupnisek M., Misic M., Vuletic L.B., et al
If you are using a GLP-1 medication, you may notice changes in appetite and how much you eat
Clinical studies have shown that at the time of diagnosis, -cell mass and function are significantly reduced in patients with T2DM [27]
Madeline Rosato Gopa Radhakrishnan, MPH Lisa Tarasenko Christian Velmer Jenna Oppenheim Rasmus Thomsen Emily Tower Olivier Zitoun Shameer Ladha Nitin Patel Luke Greenwalt #GLP1 #ObesityCare #PatientAccess #HealthcareInnovation #LifeSciencesStrategy #ValueBasedCare #HealthEquity #LuckFavorsTheBold To view or add a comment, sign in Georgia Life Sciences is proud to stand with patient advocates, providers, and employers across the state in urging #Congress to take meaningful action on pharmacy benefit manager (#PBM) reform
What circumstances or behaviors drive patient response and adherence
